Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Aurobindo Pharma Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

06 Feb 2016 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Aurobindo Pharma Ltd (AUROPHARMA-IN)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

10 Feb 2016 Thomson Reuters Stock Report 11 $25.00

Wright Investors Service Comprehensive Report for Aurobindo Pharma Ltd

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

25 Jan 2016 Wright Reports 55 $75.00

Aurobindo Pharma Ltd (AUROPHARMA) - Financial Analysis Review

Aurobindo Pharma Ltd (AUROPHARMA) - Financial Analysis Review Summary Aurobindo Pharma Ltd (Aurobindo Pharma) is a pharmaceut...

22 Jan 2016 GlobalData 58 $300.00

Spark Capital: Pharmaceuticals – ‘Down, but not out’; Initiating coverage on ARBP, DRRD, LPC and SUNP

Pharmaceuticals – ‘Down, but not out’ Recent USFDA actions on Indian companies for CGMP violations including Warning Letters ...

15 Jan 2016 Spark Capital Advisors(India) Private Limited 57 $598.00

Will Aurobindo Pharma Ltd Deliver Long-Term Returns?

07 Jan 2016 Sadif Analytics Prime 12 $25.00

Company Snapshot - Aurobindo Pharma Limited

Three Directors at Aurobindo Pharma Limited sold 46,500 shares at between 839.045INR and 846.231INR. The significance rating ...

28 Dec 2015 Directors Deals Ltd. 1 $12.00

Aurobindo Pharma Ltd (AUROPHARMA) - Financial Analysis Review

Aurobindo Pharma Ltd (AUROPHARMA) - Financial Analysis Review Summary Aurobindo Pharma Ltd (Aurobindo Pharma) is a pharmaceut...

16 Dec 2015 GlobalData 66 $300.00

MOSL: Aurobindo Pharma (Buy) - In line result - US and ARV key growth drivers

Aurobindo Pharma 2QFY16: In line result; US and ARV key growth drivers (ARBP IN, Mkt Cap USD7.5b, CMP INR856, TP INR1050, 22...

10 Nov 2015 Motilal Oswal Securities Ltd. 12 $115.00

Aurobindo Pharma (ARBP) - Qtr. Update - Dated - November 09, 2015

Aurobindo Pharma (Bloomberg: ARBP IN, BUY, TP: Rs 950; 11% upside from CMP of Rs 856) Aurobindo’s (ARBP) PAT (adj. for for...

10 Nov 2015 Axis Capital Limited 9 $92.00